Nuvectis Pharma, Inc.(NVCT)

Biotechnology · Fort Lee, NJ

$20.91-0.48 (-2.25%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

Compare

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

NVCT Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

NVCT Competitors' Interest Coverage Ratio

NVCT

Nuvectis Pharma, Inc.

Current

Market Cap

$554.85M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACRS

Aclaris Therapeutics, Inc.

vs NVCT

Market Cap

$552.89M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BLSM

BlossomHill Therapeutics, Inc.

vs NVCT

Market Cap

$554.29M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MMEDV

MiniMed Group, Inc.

vs NVCT

Market Cap

$560.00M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRMD

CorMedix Inc.

vs NVCT

Market Cap

$566.81M

Interest Coverage Ratio

53.97x

TTM Avg

53.97x

3Y Avg

53.97x

5Y Avg

53.97x

PHAT

Phathom Pharmaceuticals, Inc.

vs NVCT

Market Cap

$542.85M

Interest Coverage Ratio

-2.35x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs NVCT

Market Cap

$541.30M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs NVCT

Market Cap

$569.16M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs NVCT

Market Cap

$574.01M

Interest Coverage Ratio

-4.07x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PROK

ProKidney Corp.

vs NVCT

Market Cap

$536.32M

Interest Coverage Ratio

-41251.75x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Nuvectis Pharma, Inc. (NVCT)	$554.85M	N/A	N/A	N/A	N/A
Aclaris Therapeutics, Inc. (ACRS)vs ›	$552.89M	N/A	N/A	N/A	N/A
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$554.29M	N/A	N/A	N/A	N/A
MiniMed Group, Inc. (MMEDV)vs ›	$560.00M	N/A	N/A	N/A	N/A
CorMedix Inc. (CRMD)vs ›	$566.81M	53.97x	53.97x	53.97x	53.97x
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$542.85M	-2.35x	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$541.30M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$569.16M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$574.01M	-4.07x	N/A	N/A	N/A
ProKidney Corp. (PROK)vs ›	$536.32M	-41251.75x	N/A	N/A	N/A

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

0.00

Current Ratio

1.68

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio: N/A

NVCT Interest Coverage Ratio Metrics

NVCT Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Related Metrics